midodrine
Selected indexed studies
- Effect of midodrine versus placebo on time to vasopressor discontinuation in patients with persistent hypotension in the intensive care unit (MIDAS): an international randomised clinical trial. (Intensive Care Med, 2020) [PMID:32885276]
- Midodrine for the prevention of vasovagal syncope: a systematic review and meta-analysis. (Europace, 2022) [PMID:35025999]
- Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial. (Hepatology, 2015) [PMID:25644760]
_Worker-drafted node — pending editorial review._
Connections
midodrine is a side effect of
Sources
- Effect of midodrine versus placebo on time to vasopressor discontinuation in patients with persistent hypotension in the intensive care unit (MIDAS): an international randomised clinical trial. (2020) pubmed
- Midodrine for the prevention of vasovagal syncope: a systematic review and meta-analysis. (2022) pubmed
- Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial. (2015) pubmed
- Efficacy of adjuvant use of midodrine in patients with septic shock: An open label randomized controlled trial. (2025) pubmed
- Midodrine for severe orthostatic hypotension. (2016) pubmed
- Adjunctive Midodrine Therapy for Vasopressor-Dependent Shock in the ICU: A Systematic Review and Meta-Analysis. (2025) pubmed
- Midodrine for Recurrent Vasovagal Syncope: A Systematic Review and Meta-analysis of Randomized Control Trials. (2024) pubmed
- Putting midodrine on the MAP: An approach to liberation from intravenous vasopressors in vasodilatory shock. (2022) pubmed
- Midodrine for Intradialytic Hypotension. (2024) pubmed
- Midodrine: Associated Bradycardia. (2019) pubmed